rs9913373
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_031220.4(PITPNM3):c.1773+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0327 in 1,586,876 control chromosomes in the GnomAD database, including 1,656 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.049 ( 277 hom., cov: 33)
Exomes 𝑓: 0.031 ( 1379 hom. )
Consequence
PITPNM3
NM_031220.4 intron
NM_031220.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.05
Publications
4 publications found
Genes affected
PITPNM3 (HGNC:21043): (PITPNM family member 3) This gene encodes a member of a family of membrane-associated phosphatidylinositol transfer domain-containing proteins. The calcium-binding protein has phosphatidylinositol (PI) transfer activity and interacts with the protein tyrosine kinase PTK2B (also known as PYK2). The protein is homologous to a Drosophila protein that is implicated in the visual transduction pathway in flies. Mutations in this gene result in autosomal dominant cone dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
PITPNM3 Gene-Disease associations (from GenCC):
- cone-rod dystrophy 5Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 17-6470241-G-A is Benign according to our data. Variant chr17-6470241-G-A is described in ClinVar as Benign. ClinVar VariationId is 261942.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PITPNM3 | ENST00000262483.13 | c.1773+19C>T | intron_variant | Intron 13 of 19 | 1 | NM_031220.4 | ENSP00000262483.8 | |||
| PITPNM3 | ENST00000572795.1 | n.4279+19C>T | intron_variant | Intron 7 of 13 | 1 | |||||
| PITPNM3 | ENST00000576664.5 | n.522+19C>T | intron_variant | Intron 4 of 10 | 1 | |||||
| PITPNM3 | ENST00000421306.7 | c.1665+19C>T | intron_variant | Intron 12 of 18 | 2 | ENSP00000407882.3 |
Frequencies
GnomAD3 genomes AF: 0.0485 AC: 7379AN: 152200Hom.: 274 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
7379
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0507 AC: 10381AN: 204588 AF XY: 0.0512 show subpopulations
GnomAD2 exomes
AF:
AC:
10381
AN:
204588
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0310 AC: 44430AN: 1434558Hom.: 1379 Cov.: 31 AF XY: 0.0329 AC XY: 23369AN XY: 710978 show subpopulations
GnomAD4 exome
AF:
AC:
44430
AN:
1434558
Hom.:
Cov.:
31
AF XY:
AC XY:
23369
AN XY:
710978
show subpopulations
African (AFR)
AF:
AC:
3148
AN:
33058
American (AMR)
AF:
AC:
4334
AN:
39596
Ashkenazi Jewish (ASJ)
AF:
AC:
651
AN:
25616
East Asian (EAS)
AF:
AC:
726
AN:
38634
South Asian (SAS)
AF:
AC:
9215
AN:
83144
European-Finnish (FIN)
AF:
AC:
422
AN:
50836
Middle Eastern (MID)
AF:
AC:
439
AN:
5694
European-Non Finnish (NFE)
AF:
AC:
23011
AN:
1098482
Other (OTH)
AF:
AC:
2484
AN:
59498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
2443
4885
7328
9770
12213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1078
2156
3234
4312
5390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0486 AC: 7407AN: 152318Hom.: 277 Cov.: 33 AF XY: 0.0490 AC XY: 3650AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
7407
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
3650
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
3689
AN:
41558
American (AMR)
AF:
AC:
1288
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
96
AN:
3472
East Asian (EAS)
AF:
AC:
128
AN:
5182
South Asian (SAS)
AF:
AC:
590
AN:
4822
European-Finnish (FIN)
AF:
AC:
54
AN:
10628
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1428
AN:
68030
Other (OTH)
AF:
AC:
107
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
353
705
1058
1410
1763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
336
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Apr 27, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 26, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.